Clinical Services

DIABETES MELLITUS

DIABETES MELLITUS

Including gestational diabetes

ACCEPT:

  • If the donor has pre-diabetes
  • If the diabetes is controlled by diet alone
  • If the donor had gestational diabetes if the pregnancy ended more than 12 months ago, and treatment is not currently required
  • If the diabetes is controlled with a Biguanide (an oral hypoglycaemic medication) as a monotherapy e.g. Metformin and the type and dose have not changed in the last 4 weeks and the donor does not suffer from repeated hypoglycaemic episodes

DEFER:

  • For 4 weeks if the type or the dose of the medication has changed in last 4 weeks

 PERMANTENTLY EXCLUDE

  • If the donor requires treatment with a Biguanide e.g. Metformin in combination with other therapies
  • If the donor requires injectable medication such as Exenatide (Byetta) or Liraglutide (Victoza)
  • if the donor requires treatment with insulin at present or ever required insulin
  • if the donor suffers from repeated hypoglycaemic episodes
  • if the donor is having problems with feeling faint or fainting
  • if the donor has or had complications of diabetes such as eye, renal or cardiac disease, gangrene, or ulcers related to loss of sensation
  • If donor had a transplant of pancreatic tissue 

SEE IF RELEVANT 

 

ADDITIONAL INFORMATION

Directive 2004/33/EC has legislative requirement that prospective donors with diabetes who require treatment with insulin are permanently excluded

 

IBTS/MEDD/DSGDE/0001Attachment 4.133Ver 1.1

Sign up to Our Newsletter

Sign up to Our Newsletter

loading form...